You have 9 free searches left this month | for more free features.

Flurbiprofen axetil

Showing 1 - 25 of 79

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Postoperative Pain Trial (FA plus ropivacaine, ropivacaine alone)

Not yet recruiting
  • Postoperative Pain
  • FA plus ropivacaine
  • ropivacaine alone
  • (no location specified)
Nov 30, 2022

Flurbiprofen Axetil, Preemptive Analgesia, Postoperative Pain Trial in Beijing (Flurbiprofen axetil preoperatively, Flurbiprofen

Recruiting
  • Flurbiprofen Axetil
  • +4 more
  • Flurbiprofen axetil preoperatively
  • Flurbiprofen axetil postoperatively
  • Beijing, China
    beijing friendship hospital of Capital Medical university
Dec 17, 2021

Esophageal Cancer, Perioperative Analgesia, NSAIDs Trial in Beijing (Preemptive flurbiprofen axetil, Postoperative flurbiprofen

Not yet recruiting
  • Esophageal Cancer
  • +4 more
  • Preemptive flurbiprofen axetil
  • +2 more
  • Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Aug 15, 2022

Surgery, Anesthesia, Pain Trial in Guangzhou (Nalbuphine, Flurbiprofen Axetil, Nalbuphine and Flurbiprofen Axetil)

Completed
  • Surgery
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Jan 29, 2021

Preemptive Analgesia, Sex Difference, Flurbiprofen Axetil Trial (preemptive analgesia with flurbiprofen axetil)

Not yet recruiting
  • Preemptive Analgesia
  • +4 more
  • preemptive analgesia with flurbiprofen axetil
  • (no location specified)
Nov 6, 2020

Pain, Postoperative, Anaplasia Trial in Hangzhou (Routine Dezocine injection, Adjusted Dezocine injection, Routine Dynastat or

Unknown status
  • Pain, Postoperative
  • Anaplasia
  • Routine Dezocine injection
  • +6 more
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital of Zhejiang University School of Medi
Feb 11, 2020

Central Transport Characteristics of Flurbiprofen Axetil in

Unknown status
  • Flurbiprofen Axetil
  • +3 more
    • Beijing, Beijing, China
      Peking University People's Hospital
    Oct 14, 2019

    Postpartum Depression Trial (Esketamine is not added, Esketamine 0.2mg/kg, Esketamine 0.4mg/kg)

    Not yet recruiting
    • Postpartum Depression
    • Esketamine is not added
    • +4 more
    • (no location specified)
    Jan 27, 2022

    Opioid-free Anesthesia Trial in Beijing (T group)

    Not yet recruiting
    • Opioid-free Anesthesia
    • T group
    • Beijing, China
      Haijun Hou
    Oct 9, 2022

    Pain, Postoperative Trial in Chenzhou (Dexmedetomidine, Placebo)

    Recruiting
    • Pain, Postoperative
    • Chenzhou, Hunan, China
      Zhiming Zhang
    Nov 12, 2022

    Surgery, Anesthesia, Pain Trial in Guangzhou (Nalbuphine, Flurbiprofen Axetil, Nalbuphine and Flurbiprofen Axetil)

    Completed
    • Surgery
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University
    Dec 22, 2018

    Chronic Rhinosinusitis (Diagnosis), Surgery Trial in Beijing (Flurbiprofen Axetil, Sufentanil, Extended perioperative

    Completed
    • Chronic Rhinosinusitis (Diagnosis)
    • Surgery
    • Flurbiprofen Axetil
    • +5 more
    • Beijing, Beijing, China
      Beijing Tongren Hospital
    Aug 10, 2019

    Post Operative Pain Trial in Khon Kaen (Parecoxib + paracetamol, Normal saline)

    Not yet recruiting
    • Post Operative Pain
    • Parecoxib + paracetamol
    • Normal saline
    • Khon Kaen, Thailand
      Dr. Sirirat Tribuddharat
    Mar 3, 2023

    Lidocaine, Analgesia, Pain, Postoperative Trial (Lidocaine, normal saline)

    Not yet recruiting
    • Lidocaine
    • +3 more
    • (no location specified)
    Jun 12, 2023

    Postoperative Pain Trial (Multi-modal analgesia for Anes. Group, Multi-modal analgesia for Surg. Group, Multi-modal analgesia

    Not yet recruiting
    • Postoperative Pain
    • Multi-modal analgesia for Anes. Group
    • +2 more
    • (no location specified)
    Aug 27, 2023

    Mammary Cancer, Serratus Anterior Plane Block, Postoperative Pain Trial in Shanghai (Double-point SAPB, Single-point SAPB)

    Recruiting
    • Mammary Cancer
    • +2 more
    • Double-point SAPB
    • Single-point SAPB
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Mar 17, 2022

    Cough, Upper Respiratory Tract Infections Trial in Carlton (Flurbiprofen Oral Lozenge, Difflam, Flurbiprofen 8.75 MG)

    Recruiting
    • Cough
    • Upper Respiratory Tract Infections
    • Flurbiprofen Oral Lozenge
    • +2 more
    • Carlton, Victoria, Australia
      University of Melbourne
    Jul 23, 2023

    Hip Arthropathy Trial in Wuhan (the same-day discharge surgery)

    Recruiting
    • Hip Arthropathy
    • the same-day discharge surgery
    • Wuhan, Hubei, China
      Wuhan Union Hospital
    May 23, 2021

    Periodontitis Chronic Generalized Severe Trial in Beirut (2.5% flurbiprofen, 98% aloe vera, Placebo)

    Completed
    • Periodontitis Chronic Generalized Severe
    • 2.5% flurbiprofen
    • +2 more
    • Beirut, Lebanon
      Beirut Arab University
    Sep 11, 2023

    Postoperative Pain Trial in Ljubljana (Paracetamol and Ibuprofen, Pregabalin 150mg, Placebo)

    Recruiting
    • Postoperative Pain
    • Paracetamol and Ibuprofen
    • +2 more
    • Ljubljana, Slovenia
      University Medical Centre Ljubljana
    Feb 9, 2022

    Healthy Volunteers Trial (BMS-986196, Caffeine, Montelukast)

    Not yet recruiting
    • Healthy Volunteers
    • (no location specified)
    May 1, 2023

    Healthy Volunteers Trial in Lenexa (BMS-986419, Caffeine, Bupropion)

    Not yet recruiting
    • Healthy Volunteers
    • Lenexa, Kansas
      Local Institution - 0001
    Jun 27, 2023

    Postoperative Nausea and Vomiting in Chinese Han Population

    Completed
    • Breast Neoplasms
    • Anesthesia, General
      • (no location specified)
      Sep 13, 2020

      Healthy Trial in Berlin (ACT-539313, Flurbiprofen, Omeprazole)

      Completed
      • Healthy
      • Berlin, Germany
        CRS Clinical Research Services Berlin GmbH
      May 3, 2022

      Healthy Volunteers Trial (1024)

      Not yet recruiting
      • Healthy Volunteers
      • (no location specified)
      May 6, 2022